![](/img/cover-not-exists.png)
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer
Schmittel, A., Sebastian, M., Fischer von Weikersthal, L., Martus, P., Gauler, T. C., Kaufmann, C., Hortig, P., Fischer, J. R., Link, H., Binder, D., Fischer, B., Caca, K., Eberhardt, W. E. E., KeilhoVolume:
22
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdq652
Date:
August, 2011
File:
PDF, 176 KB
english, 2011